SU101 combined with mitoxantrone: Hormone-refractory prostate cance, reduction of prostate specific antigen levels and pain reduction

Sugen Inc. (SUGN), Redwood City, Calif. Product: SU101 combined with mitoxantrone Indication: Treat hormone refractory prostate cancer Status: SUGN will initiate a Phase II safety and pharmacokinetic ...